{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:23:59Z","timestamp":1776507839474,"version":"3.51.2"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T00:00:00Z","timestamp":1448841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143941","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T18:48:08Z","timestamp":1448909288000},"page":"e0143941","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose"],"prefix":"10.1371","volume":"10","author":[{"given":"Salheen M.","family":"Salheen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Panchapakesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen L.","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","article-title":"Endothelial dysfunction in diabetes","volume":"130","author":"AS De Vriese","year":"2000","journal-title":"Br J Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2010.03.048","article-title":"Reactive oxygen species and endothelial function in diabetes","volume":"636","author":"Z Fatehi-Hassanabad","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"IM Stratton","year":"2000","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1096\/fasebj.3.9.2545495","article-title":"Endothelium-derived relaxing and contracting factors","volume":"3","author":"RF Furchgott","year":"1989","journal-title":"FASEB J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/sonc.2002.37264","article-title":"Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications","volume":"29","author":"N Ferrara","year":"2002","journal-title":"Semin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/jmcc.1998.0840","article-title":"The alternative: EDHF","volume":"31","author":"M Feletou","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1476-5381.2010.01023.x","article-title":"Impairment of both nitric oxide\u2010mediated and EDHF\u2010type relaxation in small mesenteric arteries from rats with streptozotocin\u2010induced diabetes","volume":"162","author":"C Leo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2015.02.003","article-title":"The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose","volume":"94","author":"S Salheen","year":"2015","journal-title":"Pharmacol Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"DJ Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc07-0228","article-title":"Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes Preclinical biology and mechanisms of action","volume":"30","author":"DJ Drucker","year":"2007","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00262-009-0728-1","article-title":"On the origin of serum CD26 and its altered concentration in cancer patients","volume":"58","author":"OJ Cordero","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tips.2009.08.003","article-title":"Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?","volume":"30","author":"R Yazbeck","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MED.0b013e3280a02f65","article-title":"Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus","volume":"14","author":"J Rosenstock","year":"2007","journal-title":"Curr Op Endocrin Diab Obes"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.106.100982","article-title":"Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts","volume":"317","author":"T Zhao","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","article-title":"Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy","volume":"110","author":"LA Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1152\/ajpendo.00373.2007","article-title":"Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride","volume":"293","author":"A Basu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.abb.2008.08.001","article-title":"GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP","volume":"478","author":"BD Green","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/en.2013-1096","article-title":"Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats","volume":"154","author":"AR Aroor","year":"2013","journal-title":"Endocrinology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/oby.20833","article-title":"DPP4 Inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat","volume":"22","author":"R Nistala","year":"2014","journal-title":"Obesity"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvs246","article-title":"Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition","volume":"96","author":"S Kr\u00f6ller-Sch\u00f6n","year":"2012","journal-title":"Cardiovasc Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2840-12-125","article-title":"Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate\/insulin-like growth factor II receptor","volume":"12","author":"Y Ishibashi","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1440-1681.1992.tb00420.x","article-title":"Assessing vascular reactivity of arteries in the small vessel myograph","volume":"19","author":"GA McPherson","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"MJ Mulvany","year":"1977","journal-title":"Circ Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.02.004","article-title":"Effect of linagliptin, alone and in combination with voglibose or exendin-4, on glucose control in male ZDF rats","volume":"729","author":"RB Jones","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-014-0157-0","article-title":"DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure","volume":"13","author":"N Koibuchi","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ijcard.2014.07.023","article-title":"Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity","volume":"176","author":"S Yamagishi","year":"2014","journal-title":"Int J Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/ars.2007.1989","article-title":"Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension","volume":"10","author":"E Schulz","year":"2008","journal-title":"Antiox Redox Sig"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","article-title":"Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications","volume":"11","author":"CE Tabit","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s001250051140","article-title":"Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration","volume":"42","author":"G Pieper","year":"1999","journal-title":"Diabetologia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1152\/ajpheart.01197.2009","article-title":"Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery","volume":"299","author":"CH Leo","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/01.STR.0000231654.79017.df","article-title":"Impairment of Dilator Responses of Cerebral Arterioles During Diabetes Mellitus Role of Inducible NO Synthase","volume":"37","author":"J Kitayama","year":"2006","journal-title":"Stroke"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00424-010-0817-1","article-title":"Endothelium-derived hyperpolarising factors and associated pathways: a synopsis","volume":"459","author":"G Edwards","year":"2010","journal-title":"Pflugers Arch"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1152\/ajpheart.01197.2009","article-title":"Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery","volume":"299","author":"CH Leo","year":"2010","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.bjp.0701258","article-title":"Alterations in endothelium\u2010dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin\u2010induced diabetic rats","volume":"121","author":"M Fukao","year":"1997","journal-title":"Br J Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1152\/ajpheart.00954.2002","article-title":"Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats","volume":"285","author":"T Matsumoto","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1152\/ajpheart.00303.2005","article-title":"Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats","volume":"289","author":"T Matsumoto","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.bjp.0706748","article-title":"Impaired small-conductance Ca2<sup>+<\/sup>-activated K<sup>+<\/sup> channel-dependent EDHF responses in Type II diabetic ZDF rats","volume":"148","author":"MP Burnham","year":"2006","journal-title":"Br J Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/bjp.2008.108","article-title":"The expression and function of Ca2+\u2010sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes","volume":"154","author":"AH Weston","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.vph.2006.02.007","article-title":"Specific impairment of endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from streptozotocin-induced diabetic mice","volume":"44","author":"T Matsumoto","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bjp.0703354","article-title":"Mechanisms underlying the attenuation of endothelium\u2010dependent vasodilatation in the mesenteric arterial bed of the streptozotocin\u2010induced diabetic rat","volume":"130","author":"A Makino","year":"2000","journal-title":"Br J Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2008.05.010","article-title":"Inhibition of superoxide anion-mediated impairment of endothelium by treatment with luteolin and apigenin in rat mesenteric artery","volume":"83","author":"X Ma","year":"2008","journal-title":"Life Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T02:31:52Z","timestamp":1567391512000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143941"}},"subtitle":[],"editor":[{"given":"William","family":"Durante","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143941","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,30]]}}}